These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25415323)

  • 41. Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia.
    Guihot A; Dentone C; Assoumou L; Parizot C; Calin R; Seang S; Soulié C; Marcelin AG; Calvez V; Autran B; Katlama C; Costagliola D; Carcelain G
    AIDS; 2016 Jan; 30(2):327-30. PubMed ID: 26186129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: a 48-week matched prospective cohort study.
    Hileman CO; Carman TL; Longenecker CT; Labbato DE; Storer NJ; White CA; McComsey GA
    Antivir Ther; 2013; 18(7):921-9. PubMed ID: 23756436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.
    Hsue PY; Hunt PW; Schnell A; Kalapus SC; Hoh R; Ganz P; Martin JN; Deeks SG
    AIDS; 2009 Jun; 23(9):1059-67. PubMed ID: 19390417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and risk of residual viremia after ART in low- and middle-income countries: A cross-sectional study.
    Gatechompol S; Zheng L; Bao Y; Avihingsanon A; Kerr SJ; Kumarasamy N; Hakim JG; Maldarelli F; Gorelick RJ; Welker JL; Lifson JD; Hosseinipour MC; Eron JJ; Ruxrungtham K
    Medicine (Baltimore); 2021 Sep; 100(35):e26817. PubMed ID: 34477118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy: Comparison with a healthy control group in a 2-year prospective study.
    Di Yacovo S; Saumoy M; Sánchez-Quesada JL; Navarro A; Sviridov D; Javaloyas M; Vila R; Vernet A; Low H; Peñafiel J; García B; Ordoñez-Llanos J; Podzamczer D
    PLoS One; 2020; 15(8):e0237739. PubMed ID: 32817629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of cumulative smoking exposure and duration of smoking cessation on carotid artery structure.
    Kweon SS; Lee YH; Shin MH; Choi JS; Rhee JA; Choi SW; Ryu SY; Kim BH; Nam HS; Jeong SK; Park KS
    Circ J; 2012; 76(8):2041-7. PubMed ID: 22664416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV.
    Portilla J; Moreno-Pérez O; Serna-Candel C; Escoín C; Alfayate R; Reus S; Merino E; Boix V; Giner L; Sánchez-Payá J; Picó A
    J Int AIDS Soc; 2014; 17(1):18945. PubMed ID: 24836607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac function in vertically HIV-infected children and adolescents in the era of highly active antiretroviral therapy.
    Sainz T; Álvarez-Fuente M; Fernández-Jiménez R; González-Tomé MI; de José MI; Ramos JT; Navarro ML; Martínez J; García-Hortelano M; Medrano C; Muñoz-Fernández MÁ; Mellado MJ;
    Pediatr Infect Dis J; 2015 May; 34(5):e125-31. PubMed ID: 25876103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy.
    Cyktor JC; Bosch RJ; Mar H; Macatangay BJ; Collier AC; Hogg E; Godfrey C; Eron JJ; McMahon DK; Mellors JW; Gandhi RT;
    J Infect Dis; 2021 Feb; 223(3):462-470. PubMed ID: 32603416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perceived stress, common carotid intima media thickness and occupational status: The Paris Prospective Study III.
    Wiernik E; Lemogne C; Thomas F; Perier MC; Guibout C; Nabi H; Laurent S; Pannier B; Boutouyrie P; Jouven X; Empana JP
    Int J Cardiol; 2016 Oct; 221():1025-30. PubMed ID: 27447809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.
    Ross AC; Rizk N; O'Riordan MA; Dogra V; El-Bejjani D; Storer N; Harrill D; Tungsiripat M; Adell J; McComsey GA
    Clin Infect Dis; 2009 Oct; 49(7):1119-27. PubMed ID: 19712036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.
    Barbour JD; Jalbert EC; Chow DC; Gangcuangco LM; Norris PJ; Keating SM; Heitman J; Nagamine L; Seto T; Ndhlovu LC; Nakamoto BK; Hodis HN; Parikh NI; Shikuma CM
    Atherosclerosis; 2014 Jan; 232(1):52-8. PubMed ID: 24401216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients.
    Fabbiani M; Ciccarelli N; Tana M; Farina S; Baldonero E; Di Cristo V; Colafigli M; Tamburrini E; Cauda R; Silveri MC; Grima P; Di Giambenedetto S
    HIV Med; 2013 Mar; 14(3):136-44. PubMed ID: 22994586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelial activation and cardiometabolic profiles of treated and never-treated HIV infected Africans.
    Fourie CM; Schutte AE; Smith W; Kruger A; van Rooyen JM
    Atherosclerosis; 2015 May; 240(1):154-60. PubMed ID: 25795556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship.
    Penot P; Héma A; Bado G; Sombié D; Kaboré FN; Poda A; Michon C; Terzolo O; Traoré A; Slama L; Sawadogo A; Laurent C
    AIDS Care; 2018 Dec; 30(12):1502-1506. PubMed ID: 29991274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings.
    Shete A; Dhayarkar S; Dhamanage A; Kulkarni S; Ghate M; Sangle S; Medhe U; Verma V; Rajan S; Hattori T; Gangakhedkar R
    AIDS Res Ther; 2020 Jul; 17(1):43. PubMed ID: 32678033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of the tissue factor and its inhibitor in the development of subclinical atherosclerosis in people living with HIV.
    Barska K; Kwiatkowska W; Knysz B; Arczyńska K; Karczewski M; Witkiewicz W
    PLoS One; 2017; 12(7):e0181533. PubMed ID: 28749986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk Prediction Tool for Medical Appointment Attendance Among HIV-Infected Persons with Unsuppressed Viremia.
    Woodward B; Person A; Rebeiro P; Kheshti A; Raffanti S; Pettit A
    AIDS Patient Care STDS; 2015 May; 29(5):240-7. PubMed ID: 25746288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunosuppression and HIV Viremia Associated with More Atherogenic Lipid Profile in Older People with HIV.
    Levy ME; Greenberg AE; Magnus M; Younes N; Castel A;
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):81-91. PubMed ID: 30353737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of HIV-Infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis.
    Gómez-Garre D; Estrada V; Ortega-Hernández A; Muñoz-Pacheco P; Serrano-Villar S; Avila M; Fuentes-Ferrer M; Tejerina T; Fernández-Cruz A
    J Acquir Immune Defic Syndr; 2012 Dec; 61(5):545-51. PubMed ID: 22842847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.